Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
3.
Curr Atheroscler Rep ; 16(1): 377, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24277654

ABSTRACT

Statins are effective in the prevention of coronary events and the treatment of acute coronary syndromes. However, their efficacy and safety in patients with heart failure (HF) is still a matter of debate. On the basis of literature evidence from subgroup analysis, retrospective, prospective cohort studies, and randomized controlled trials, in this review we try to answer the following question: Is statin therapy in HF patients for good, for bad, or indifferent? Some studies showed a negative impact of low cholesterol levels in patients with severe HF (endotoxin-lipoprotein hypothesis and coenzyme Q10 hypothesis). On the other hand, a large amount of literature demonstrates that in patients with HF, statins have a positive impact on survival and other outcomes, regardless of whether the HF was of ischemic or nonischemic origin, which is related to a combination of mechanisms (pleiotropic effects and cholesterol reduction). Much of this evidence, however, comes from observational and retrospective studies and subgroup analyses of statin use in patients with HF. Randomized clinical trials examining the efficacy of statins in HF (GISSI-HF and CORONA) did not show a benefit in mortality for patients with HF randomized to receive statins. Nevertheless, a meta-analysis found that statin therapy does not decrease all-cause or cardiovascular mortality but significantly decreases the rate of hospitalization for worsening HF and increased left ventricular ejection fraction compared with placebo.


Subject(s)
Heart Failure/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Animals , Clinical Trials as Topic , Humans , Treatment Outcome , Ubiquinone/analogs & derivatives , Ubiquinone/metabolism
5.
Eur J Echocardiogr ; 11(6): 477-81, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20106880

ABSTRACT

We report the case of an 86-year-old man referred for abdominal pain and ECG signs of inferior myocardial infarction. Transthoracic, transoesophageal and contrast echocardiographs showed a septal intra-mural haematoma, dissecting the right ventricle wall and partially obliterating the right ventricle lumen. A patent communication with left ventricle with extensive wall thrombosis was present at Doppler examination within dissecting haematoma. Although the patient refused any surgical treatment, a 3-month follow-up was uneventful.


Subject(s)
Cardiomyopathies/etiology , Heart Ventricles/pathology , Hematoma/etiology , Hemodynamics , Myocardial Infarction/complications , Aged, 80 and over , Cardiomyopathies/diagnostic imaging , Contrast Media , Echocardiography , Echocardiography, Transesophageal , Heart Ventricles/diagnostic imaging , Hematoma/diagnostic imaging , Humans , Male , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/pathology , Rupture/diagnostic imaging , Rupture/etiology , Rupture/pathology
SELECTION OF CITATIONS
SEARCH DETAIL